- Release Date: 03/09/12 18:03
- Summary: RELINT: FPH: Disclosure of Offices and Director Relevant Interests
- Price Sensitive: No
- Download Document 10.87KB
FPH 03/09/2012 16:03 RELINT REL: 1603 HRS Fisher & Paykel Healthcare Corporation Limited RELINT: FPH: Disclosure of Offices and Director Relevant Interests Name of director or officer of public issuer: Deborah Anne BAILEY Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Vice President Human Resources B Securities in public issuer or related body corporate to which this disclosure relates Number, class, and type of securities: "i) 60,000 options to acquire ordinary shares ii) 10,000 Performance Share Rights" C Nature of relevant interest and name of registered holder Nature of relevant interest in securities: Beneficial Ownership Name of registered holder of securities Deborah Anne BAILEY D Details of acquisitions and disposals If the relevant interest was acquired-- Date of acquisition: 30 August 2012 Consideration paid for acquisition: NZ$Nil If the relevant interest was disposed of-- Date of disposal: Not applicable Consideration paid for disposal: Not applicable Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acquisition took place: "i) Issue of 60,000 options to acquire ordinary shares ii) Issue of 10,000 Performance Share Rights" E Total number of transactions this notice relates to: Two F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 31 August 2012 Name of director or officer of public issuer: Lewis George GRADON Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Senior VP Products and Technology B Securities in public issuer or related body corporate to which this disclosure relates Number, class, and type of securities: "i) 155,000 options to acquire ordinary shares ii) 24,000 Performance Share Rights" C Nature of relevant interest and name of registered holder Nature of relevant interest in securities: Beneficial Ownership Name of registered holder of securities Lewis George GRADON D Details of acquisitions and disposals If the relevant interest was acquired-- Date of acquisition: 30 August 2012 Consideration paid for acquisition: NZ$Nil If the relevant interest was disposed of-- Date of disposal: Not Applicable Consideration paid for disposal: Not Applicable Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acquisition took place: "i) Issue of 155,000 options to acquire ordinary shares ii) Issue of 24,000 Performance Share Rights" E Total number of transactions this notice relates to: Two F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 31 August 2012 Name of director or officer of public issuer: Michael Robert BATTY Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Group Operations Manager B Securities in public issuer or related body corporate to which this disclosure relates Number, class, and type of securities: "i) 28,000 options to acquire ordinary shares ii) 5,000 Performance Share Rights" C Nature of relevant interest and name of registered holder Nature of relevant interest in securities: Beneficial interest Name of registered holder of securities Michael Robert BATTY D Details of acquisitions and disposals If the relevant interest was acquired-- Date of acquisition: 30 August 2012 Consideration paid for acquisition: NZ$Nil If the relevant interest was disposed of-- Date of disposal: Not Applicable Consideration paid for disposal: Not Applicable Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acquisition took place: "i) Issue of 28,000 options to acquire ordinary shares ii) Issue of 5,000 Performance Share Rights" E Total number of transactions this notice relates to: Two F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 31 August 2012 Name of director or officer of public issuer: Paul ANDREASSI Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Vice President Quality & Regulatory B Securities in public issuer or related body corporate to which this disclosure relates Number, class, and type of securities: "i) 95,000 options to acquire ordinary shares ii) 16,000 Performance Share Rights" C Nature of relevant interest and name of registered holder Nature of relevant interest in securities: Beneficial interest Name of registered holder of securities Paul ANDREASSI D Details of acquisitions and disposals If the relevant interest was acquired-- Date of acquisition: 30 August 2012 Consideration paid for acquisition: NZ$Nil If the relevant interest was disposed of-- Date of disposal: Not Applicable Consideration paid for disposal: Not Applicable Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acquisition took place: "i) Issue of 95,000 options to acquire ordinary shares ii) Issue of 16,000 Performance Share Rights" E Total number of transactions this notice relates to: Two F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 23 September 2011 Name of director or officer of public issuer: Paul Nigel SHEARER Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Senior VP Sales & Marketing B Securities in public issuer or related body corporate to which this disclosure relates Number, class, and type of securities: "i) 155,000 options to acquire ordinary shares ii) 24,000 Performance Share Rights" C Nature of relevant interest and name of registered holder Nature of relevant interest in securities: Beneficial Ownership Name of registered holder of securities Paul Nigel SHEARER D Details of acquisitions and disposals If the relevant interest was acquired-- Date of acquisition: 30 August 2012 Consideration paid for acquisition: NZ$Nil If the relevant interest was disposed of-- Date of disposal: Not applicable Consideration received from disposal: Not applicable Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acquisition took place: "i) Issue of 155,000 options to acquire ordinary shares ii) Issue of 24,000 Performance Share Rights" E Total number of transactions this notice relates to: Two F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 31 August 2012 Name of director or officer of public issuer: Antony George BARCLAY Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Chief Financial Officer & Company Secretary B Securities in public issuer or related body corporate to which this disclosure relates Number, class, and type of securities: "i) 105,000 options to acquire ordinary shares ii) 17,000 Performance Share Rights" C Nature of relevant interest and name of registered holder Nature of relevant interest in securities: Beneficial Ownership Name of registered holder of securities Antony George BARCLAY D Details of acquisitions and disposals If the relevant interest was acquired-- Date of acquisition: 30 August 2012 Consideration paid for acquisition: NZ$Nil If the relevant interest was disposed of-- Date of disposal: Not applicable Consideration received from disposal: Not applicable Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acquisition took place: "i) Issue of 105,000 options to acquire ordinary shares ii) Issue of 17,000 Performance Share Rights" E Total number of transactions this notice relates to: Two F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 31 August 2012 Name of director or officer of public issuer: Winston FONG Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Vice President ICT B Securities in public issuer or related body corporate to which this disclosure relates Number, class, and type of securities: "i) 60,000 options to acquire ordinary shares ii) 10,000 Performance Share Rights" C Nature of relevant interest and name of registered holder Nature of relevant interest in securities: Beneficial Ownership Name of registered holder of securities Winston FONG D Details of acquisitions and disposals If the relevant interest was acquired-- Date of acquisition: 30 August 2012 Consideration paid for acquisition: NZ$Nil If the relevant interest was disposed of-- Date of disposal: Not Applicable Consideration paid for disposal: Not Applicable Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acquisition took place: "i) Issue of 60,000 options to acquire ordinary shares ii) Issue of 10,000 Performance Share Rights" E Total number of transactions this notice relates to: Two F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 16 December 2011 Name of director or officer of public issuer: Michael Grenfell DANIELL Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Managing Director & Chief Executive Officer B Securities in public issuer or any related body corporate in which director or officer has relevant interest Number, class, and type of securities: "i) 200,000 options to acquire ordinary shares ii) 30,000 Performance Share Rights" C Nature of relevant interest and name of registered holder Nature of relevant interest in securities: Beneficial Ownership Name of registered holder of securities Michael Grenfell DANIELL D Details of acquisitions and disposals If the relevant interest was acquired-- Date of issue 30 August 2012 Consideration received for acquisition NZ$Nil If the relevant interest was disposed of-- Date of disposal: Not applicable Consideration received from disposal: Not applicable Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acquisition took place: "i) Issue of 200,000 options to acquire ordinary shares ii) Issue of 30,000 Performance Share Rights " E Total number of transactions this notice relates to: Two F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 31 August 2012 End CA:00226843 For:FPH Type:RELINT Time:2012-09-03 16:03:15
Ann: RELINT: FPH: Disclosure of Offices and Direc
Add to My Watchlist
What is My Watchlist?
